A detailed history of Fmr LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Fmr LLC holds 4,922,555 shares of ASND stock, worth $587 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,922,555
Previous 4,938,461 0.32%
Holding current value
$587 Million
Previous $747 Million 10.07%
% of portfolio
0.04%
Previous 0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$121.07 - $153.67 $1.93 Million - $2.44 Million
-15,906 Reduced 0.32%
4,922,555 $671 Million
Q1 2024

May 13, 2024

SELL
$123.45 - $159.4 $21.7 Million - $28 Million
-175,908 Reduced 3.44%
4,938,461 $747 Million
Q4 2023

Feb 13, 2024

SELL
$86.1 - $127.36 $1.89 Million - $2.79 Million
-21,913 Reduced 0.43%
5,114,369 $644 Million
Q3 2023

Nov 13, 2023

SELL
$86.5 - $103.97 $391,239 - $470,256
-4,523 Reduced 0.09%
5,136,282 $481 Million
Q2 2023

Aug 11, 2023

SELL
$69.96 - $97.84 $794,745 - $1.11 Million
-11,360 Reduced 0.22%
5,140,805 $459 Million
Q1 2023

May 11, 2023

SELL
$104.9 - $126.78 $8.07 Million - $9.75 Million
-76,905 Reduced 1.47%
5,152,165 $552 Million
Q4 2022

Feb 13, 2023

SELL
$99.42 - $131.97 $4.95 Million - $6.57 Million
-49,795 Reduced 0.94%
5,229,070 $639 Million
Q3 2022

Nov 10, 2022

SELL
$84.03 - $110.23 $1.2 Million - $1.57 Million
-14,255 Reduced 0.27%
5,278,865 $545 Million
Q2 2022

Aug 12, 2022

SELL
$78.08 - $117.61 $4.81 Million - $7.25 Million
-61,636 Reduced 1.15%
5,293,120 $492 Million
Q1 2022

May 13, 2022

SELL
$102.18 - $135.75 $121,287 - $161,135
-1,187 Reduced 0.02%
5,354,756 $628 Million
Q4 2021

Feb 14, 2022

SELL
$127.1 - $169.66 $4.34 Million - $5.79 Million
-34,156 Reduced 0.63%
5,355,943 $721 Million
Q3 2021

Nov 15, 2021

BUY
$112.67 - $176.92 $806,942 - $1.27 Million
7,162 Added 0.13%
5,390,099 $859 Million
Q2 2021

Aug 13, 2021

BUY
$121.62 - $145.29 $655 Million - $782 Million
5,382,937 New
5,382,937 $708 Million

Others Institutions Holding ASND

About Ascendis Pharma A/S


  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $6.65B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.